000 01683 a2200445 4500
005 20250512005746.0
264 0 _c19890901
008 198909s 0 0 eng d
022 _a0003-4819
024 7 _a10.7326/0003-4819-111-4-273
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcGuire, W P
245 0 0 _aTaxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
_h[electronic resource]
260 _bAnnals of internal medicine
_cAug 1989
300 _a273-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAlkaloids
_xadministration & dosage
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aArrhythmias, Cardiac
_xchemically induced
650 0 4 _aCisplatin
_xadverse effects
650 0 4 _aDrug Evaluation
650 0 4 _aEpilepsy, Tonic-Clonic
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHematologic Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aJoint Diseases
_xchemically induced
650 0 4 _aMuscular Diseases
_xchemically induced
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
650 0 4 _aPain
_xchemically induced
650 0 4 _aPeripheral Nervous System Diseases
_xchemically induced
700 1 _aRowinsky, E K
700 1 _aRosenshein, N B
700 1 _aGrumbine, F C
700 1 _aEttinger, D S
700 1 _aArmstrong, D K
700 1 _aDonehower, R C
773 0 _tAnnals of internal medicine
_gvol. 111
_gno. 4
_gp. 273-9
856 4 0 _uhttps://doi.org/10.7326/0003-4819-111-4-273
_zAvailable from publisher's website
999 _c2575230
_d2575230